Active, not recruitingPhase 2NCT03190915

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Studying Juvenile myelomonocytic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Elliot Stieglitz
Children's Oncology Group
Intervention
Bone Marrow Aspiration and Biopsy(procedure)
Enrollment
10 enrolled
Eligibility
1-21 years · All sexes
Timeline
20182023

Study locations (20)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03190915 on ClinicalTrials.gov
← Back to all trials